HEPATO PERNAMBUCO 2019

XXIII WORKSHOP INTERNACIONAL DE HEPATITES VIRAIS DE PERNAMBUCO
XII SIMPÓSIO DE TRANSPLANTE DE FÍGADO, CARCINOMA HEPATOCELULAR E HIPERTENSÃO PORTA – BRASIL/ INGLATERRA
II SIMPÓSIO INTERNACIONAL DE NASH
CURSO PRÉ-CONGRESSO: ONCOLOGIA CLÍNICA E CIRÚRGICA EM TUMORES HEPATOBILIOPANCREÁTICOS

29 a 31 de maio de 2019 no
Auditório do Instituto do Fígado e
Transplantes de Pernambuco


APRESENTAÇÕES

MAY 29 (WEDNESDAY)
Local: INSTITUTO DO FÍGADO E TRANSPLANTES DE PE
PRE–CONGRESS MEETING: HPB ONCOLOGY

8h30 – 18h30

Accreditation and Registration

09h00 – 09h15

 

Opening Session

Dra. Leila Beltrão Pereira (PE) / Dr. Hector Vilca-Melendez (UK)

09h15 – 10h00

 

Magna Conference: Pancreatic Surgery – Minimally Invasive Advances and Challenges

Moderators: Dr. Luciano Beltrão Pereira (SP) e Dr. Roberto Lustosa (PE)

Speaker: Dr. Michael Kendrick (USA)

 

9h45 – 10h00

Discussion

10h00 – 10h30

 

Conference: Liver imagery: new technologies for more accurate diagnosis and staging in HPB tumors

Presidente: Dra. Marilia Abath (PE)

Speaker:  (Púbio Viana ) – (SP)

10h30 – 10h45

 

Coffee–break

10h45 – 12h30

 

Roundtable – Pancreatic-biliary tumors

Moderators: Dr. César Lyra (PE) e Dr. Euclides Martins (PE)

 

10h45 – 11h00

Precise Medicine: molecular oncology era.

Speaker: Cristiana Tavares (PE)

 

11h00 – 11h15

Pancretic Cancer Treatment - Algorithm

Speaker: Dr. Ernesto Sasaki Imakuma (SP)

 

11h15 – 11h30

Cholangiocarcinoma: Until where can the surgeon go? 

Speaker: Dr. Agnaldo Soares (MG)

 

11h30 – 11h45

Neoadjuvant chemotherapy in pancreatic cancer. Always?

Speaker: Dr. Heberton Teixeira (PE)

 

11h45 – 12h00

The future of transplantation in HPB oncology

Speaker:  Dr. Álvaro Alcaraz (ARG)

 

12h00 – 12h30

Discussion

12h30 – 14h00

 

Lunch

14h00 – 16h00

 

Roundtable – Hepatocelular Carcinoma

Speaker:

 

14h00 – 14h15

Epidemiology, risk factors “around the world”

Speaker: Dr. José Eymard (PB)

 

14h15 – 14h30

Hepatocelular Carcinoma and metabolic syndrome.

Speaker: Dr. Mohammad Siddiqui (USA)

 

14h30 – 14h45

Discrepancy between the EASL, AASLD and APASL guidelines. How to deal?

Speaker: Dra. Ilka Boin (SP)

 

14h45 – 15h00

Small tumors (~ 2.0cm) in cirrhotic CHILD A - Which is the best therapeutic option?

Speaker: Dr. Renato Silva (SP)

 

15h00 – 15h15

TACE and Radioablation: When and how far to go?

Speaker: Dra. Marilia Abath (PE)

 

15h15 – 15h30

Systemic therapeutic strategies - currently and in the future.

Palestrante: Dr. José Fernando do Prado Moura (PE)

 

15h30 – 16h00

Discussion

16h00 – 16h30

 

Coffee–break / Visit to Stands

16h30 – 17h00

 

Conference: Evolving in Liver Transplantation: new technologies

President: Dr. Luciano Beltrão Pereira (SP)

Speaker: Dr. Hector Vilca-Melendez (UK)

17h00 – 18h30

 

Roundtable – Liver Transplantation and Portal Hypertension

Moderators: Dr. Fábio Moura (PE) / Dr. Huygens Garcia (CE)

 

17h00 - 17h15

Liver transplantation: selected indications today and in the future

Speaker: Dr. Luiz Carneiro (SP)                           

 

17h15 - 17h30

Liver Transplant: a change in cirrhosis etiologies brings new challenges?

Speaker: Dr. Hector Vilca-Melendez (UK)

 

17h30 - 17h45

Management of difficult ascitis

Speaker: Dr. André Lyra (BA)

 

17h45 - 18h00

Optimal management of portal hypertension

Speaker: Dr. José Eymard (PB)

 

18h00 – 18h30

Discussion

18h30

 

Encerramento das atividades

MAY 30 (THURSDAY)
Local: INSTITUTO DO FÍGADO E TRANSPLANTES DE PE

07h30 – 08h30

Accreditation and Registration

08h30 – 10h10

 

Roundtable – Hepatitis B

Speaker: Dra. Erika Rabelo (PE) / Ana Lúcia Coutinho (PE)

 

08h30 – 08h45

The impact of HBV therapy on the public health system

 Speaker: Dr. David Urbaez (DF)

 

08h45 – 09h00

Treatment of hepatitis B:  The guidelines in real life.

Speaker: Dr. Andre Lyra (BA)

 

09h00 – 09h15

NUCs - their long-term effectiveness and the dilemma of when to stop

Speaker: Paulo Abrão (SP)

 

09h15 – 09h30

When and how to use quantitative HBSAG?

Speaker: Dr. Adriano Moraes (DF)

 

09h30 – 09h45

New therapeutic approaches for cure

Speaker: Dra. Suzane Ono (SP)

 

09h45 – 10h00

Discussion

10h00 – 10h30

 

Coffee–break

10h30 – 11h00

 

Conference: Elimination of hepatitis C: what have we learned from the national viral hepatitis program?

President: Dra. Valeska Brito (PE)

Speaker: Dr. Glaucio Mosimann Junior (DF)

11h00 – 13h00

 

Roundtable - Hepatite C

Hepatitis C

Moderators: Dr. Demetrius Montenegro (PE) / Dra. Andrea Dória (PE)

 

11h00 – 11h15

New drugs in PCDT 2019: New dilemmas, new solutions?

Speaker: Dr. Mário Reis (RS)

 

11h15 – 11h30

Treatment of hepatitis C in decompensated cirrhosis

Speaker: Dra. Liliana Mendes (DF)

 

11h30 – 11h45

Cost benefit of treating F0 - F1 patients

Speaker: Dra. Rosamar Rezende (SP)

 

11h45 – 12h00

Does treatment with DDAs reduce the risk of HCC?

Speaker: Dra. Rita Silva (SP)

 

12h00 – 12h15

Treatment of HBV and HCV co-infection

Speaker: Dr. Paulo Abrão (SP)

 

12h15 – 12h30

Treatment for HCV: the last issues

Speaker: Dr. Mohammad Siddiqui (USA)

 

12h30 – 13h00

Discussion

13h00 – 15h00

 

Lunch

15h00 – 15h30

 

Conference: Hepatology in the digital era

President: Dra. Sâmia Fernandes (PE)

Speaker: Dra. Mônica Viana (SP)

15h30 – 18h00

 

Clinical cases

Speaker: Dra. Leila Beltrão Pereira (PE) / Dr. Mario Reis (RS)

 

15h30 – 16h00

Number 1 – Hepatocelular Carcinoma

Dra. Ilka Boin (SP) / Dra. Dayse Aroucha (PE)

 

16h00 – 16h30

Number 2- Viral Hepatitis

Dr. Tibério Medeiros (PE) / Dr. Gustavo Guerra (PE)

 

16h30 – 17h00

Number 3 - NASH

Dra. Helma Cotrim (BA) / Dra. Cláudia Oliveira (SP)

 

17h00 – 17h30

Number 4 – Liver Transplant

Dr. Vitor Madeiro (PE) / Dr. Agnaldo Soares (MG)

 

17h30 – 18h00

Discussion

18h00

 

Closure of activities

MAY 31 (FRIDAY)
Local: INSTITUTO DO FÍGADO E TRANSPLANTES DE PERNAMBUCO

08h45 – 10h45

 

Roundtable - Burden and Mechanisms of Disease

Moderators: Dra. Leila Beltrão Pereira (PE) / Dra. Cláudia Oliveira (SP)

 

08h45 – 09h00

Real world evidence of burden of disease from NAFLD/NASH

Speaker: Dra. Deborah Crespo (PA)

 

09h00 – 09h15

Role of NASH in long-term outcomes after SVR for HCV

Speaker: Dra. Rita Silva (SP)

 

09h15 – 09h30

Active screening for NASH is necessary in all type 2 diabetes patient

Speaker: Dra. Liliana Mendes (DF)

 

09h30 – 09h45

Role of extrahepatic factors in the pathogenesis of NASH

Speaker: Dr. Mario Reis (RS)

 

09h45 – 10h00

The hepatic pathogenesis of NASH

Speaker: Dr. Arun Sanyal (USA)

 

10h00 – 10h15

Similarities between NASH and NASH-associated cardiovascular disease

Speaker: Dr. Mohammad Siddiqui (USA)

 

10h15 – 10h45

Discussion

10h45 – 11h15

 

Coffee–break

11h15 – 13h00

 

Roundtable - Diagnostics and Therapeutics

Moderators:Dra. Leila Beltrão Pereira (PE) / Dra. Deborah Crespo (PA)

 

11h15 – 11h30

Principles of biomarker development in NASH

Speaker: Dra. Claudia Oliveira (SP)

 

11h30 – 11h45

Diagnostic approach to NAFLD- review of practice guidelines

Speaker: Dra. Helma Cotrim (BA)

 

11h45 – 12h00

Barriers to successful lifestyle intervention, physical activity and bariatric surgery

Speaker: Dra. Rosamar Resende (SP)

 

12h00 – 12h30

Current treatment and future of drug development in NASH

Speaker: Dr. Arun Sanyal (USA)

 

12h30 – 13h00

Discussion

13h00

 

Closure of activities



ORGANIZING COMMITTEE
Leila Beltrão Pereira / Nigel Heaton / Arun Sanyal / Victorino Spinelli / Dayse Aroucha / Luciano Beltrão Pereira / Fátima Barreto / Claudia Oliveira / Mario Reis Álvares-da-Silva / Fábio Moura



Patrocinadores

Realização

Apoio

Agência de viagens oficial

Tel.: 81 3224 0600 / 9 8483 2032